facebook
eISSN: 2084-9893
ISSN: 0033-2526
Dermatology Review/Przegląd Dermatologiczny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
5/2016
vol. 103
 
Share:
Share:
abstract:
Original paper

Drug reaction with eosinophilia and systemic symptoms associated with carbamazepine (DRESS syndrome) – case report and literature review

Kamila Ociepa
,
Anna Woźniacka
,
Agnieszka Żebrowska

Przegl Dermatol 2016, 103, 376–382
Online publish date: 2016/10/20
View full text Get citation
 
PlumX metrics:
Introduction. Drug reaction with eosinophilia and systemic symptoms (DRESS) is a serious, potentially life-threatening syndrome with skin lesions, internal organ involvement and eosinophilia.

Objective. To present the case of a 35-year-old woman with DRESS syndrome after 6 weeks of treatment with the anticonvulsant drug carbamazepine.

Case report. A 35-year-old woman, suffering from depression, was admitted to hospital after a single exposure to artificial ultraviolet radiation during carbamazepine therapy. Generalized maculopapular eruptions and laboratory blood test abnormalities were recognized. After withdrawal of the causative drug and treatment with corticosteroids and antihistaminic preparations, the skin lesions disappeared and the values of laboratory blood tests improved.

Conclusions. Due to the high rate of mortality in DRESS, a quick diagnosis is of crucial value. Most important is detailed history taking, immediate cessation of the causative drug, and in severe cases therapy with systemic corticosteroids. Proper diagnosis reduces the rate of fatal outcome of the disease, which is estimated at 10–38%.
keywords:

DRESS/DIHS, carbamazepine, drug eruptions



Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.